Log in to save to my catalogue

Statistics and measurable residual disease (MRD) testing: uses and abuses in hematopoietic cell tran...

Statistics and measurable residual disease (MRD) testing: uses and abuses in hematopoietic cell tran...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7462748

Statistics and measurable residual disease (MRD) testing: uses and abuses in hematopoietic cell transplantation

About this item

Full title

Statistics and measurable residual disease (MRD) testing: uses and abuses in hematopoietic cell transplantation

Publisher

London: Nature Publishing Group UK

Journal title

Bone marrow transplantation (Basingstoke), 2020-05, Vol.55 (5), p.843-850

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Series Editors’ Note
The decision whether to recommend a transplant to someone with acute leukemia in first remission is complex and challenging. Diverse, often confounded co-variates interact to influence one’s recommendation. Briefly, the decision metric can be viewed in three spheres: (1) subject-; (2) transplant-; and (3) disease-related co-...

Alternative Titles

Full title

Statistics and measurable residual disease (MRD) testing: uses and abuses in hematopoietic cell transplantation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7462748

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7462748

Other Identifiers

ISSN

0268-3369,1476-5365

E-ISSN

1476-5365

DOI

10.1038/s41409-019-0729-4

How to access this item